Get the Stockscreener App
3.60
6.98%
-0.27
After Hours:
3.57
-0.03
-0.83%
Hcw Biologics Inc stock is traded at $3.60, with a volume of 13,787.
It is down -6.98% in the last 24 hours and down -10.89% over the past month.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
See More
Previous Close:
$3.87
Open:
$3.82
24h Volume:
13,787
Relative Volume:
0.01
Market Cap:
$7.75M
Revenue:
$832.80K
Net Income/Loss:
$-21.55M
P/E Ratio:
-0.2988
EPS:
-12.0465
Net Cash Flow:
$-12.71M
1W Performance:
-6.49%
1M Performance:
-10.89%
6M Performance:
-52.83%
1Y Performance:
-79.07%
1-Day Range:
$3.58
$3.82
1-Week Range:
$3.58
$3.92
52-Week Range:
$2.77
$100.80
Hcw Biologics Inc Stock (HCWB) Company Profile
Name
Hcw Biologics Inc
Sector
Industry
Phone
954-842-2024
Address
2929 N COMMERCE PKWY, MIRAMAR
Compare HCWB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCWB
Hcw Biologics Inc
|
3.60 | 8.33M | 832.80K | -21.55M | -12.71M | -12.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Hcw Biologics Inc Stock (HCWB) Latest News
Will HCW Biologics Inc. benefit from macro trendsJuly 2025 Rallies & Real-Time Market Trend Scan - newser.com
Chart based exit strategy for HCW Biologics Inc.2025 Buyback Activity & Daily Profit Maximizing Trade Tips - newser.com
How HCW Biologics Inc. stock reacts to oil prices2025 Trading Volume Trends & Real-Time Volume Spike Alerts - newser.com
Why retail investors favor HCW Biologics Inc. stock2025 Institutional Moves & Community Consensus Picks - newser.com
Can HCW Biologics Inc. stock deliver surprise earnings beatChart Signals & Long-Term Investment Growth Plans - newser.com
Can machine learning forecast HCW Biologics Inc. recoveryJuly 2025 Outlook & Daily Entry Point Alerts - newser.com
Automated trading signals detected on HCW Biologics Inc.Earnings Growth Summary & Fast Gain Stock Trading Tips - newser.com
Why HCW Biologics Inc. stock appeals to dividend seekersJuly 2025 Price Swings & Weekly Breakout Stock Alerts - newser.com
Can HCW Biologics Inc. stock withstand economic slowdownJuly 2025 Volume & AI Driven Stock Reports - newser.com
HCW Biologics Inc. stock trend outlook and recovery pathJuly 2025 Sector Moves & Safe Entry Point Alerts - newser.com
Using Bollinger Bands to evaluate HCW Biologics Inc.2025 Growth vs Value & Daily Stock Trend Reports - newser.com
How HCW Biologics Inc. stock benefits from strong dollarPortfolio Gains Report & Daily Technical Forecast Reports - newser.com
Published on: 2025-11-02 03:00:57 - newser.com
Regression analysis insights on HCW Biologics Inc. performanceEarnings Miss & Technical Entry and Exit Alerts - newser.com
Using fundamentals and technicals on HCW Biologics Inc.Earnings Summary Report & Consistent Income Trade Recommendations - newser.com
HCW Biologics Advances Alopecia Areata Treatment with Phase 1 Study of HCW9302 - MSN
Hcw Biologics Inc Stock (HCWB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):